News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Charles Jeffrey Tan: I’m Starting a New Position as Drug Development and Phase 1 Clinical Trial Fellow at Princess Margaret Cancer Centre
Charles Jeffrey Tan/LinkedIn
Jul 5, 2025, 06:46

Charles Jeffrey Tan: I’m Starting a New Position as Drug Development and Phase 1 Clinical Trial Fellow at Princess Margaret Cancer Centre

Charles Jeffrey Tan, Drug Development and Phase 1 Clinical trial Fellow at Princess Margaret Cancer Centre, shared on LinkedIn:

“I’m happy to share that I’m starting a new position as Drug Development and Phase 1 Clinical trial Fellow at Princess Margaret Cancer Centre!”

cancer Charles Jeffrey Tan drug development OncoDaily Oncology Princess Margaret Cancer Centre
Special Coverage
Voices
Aug 15, 2025, 14:17
David Binder: Mayo Clinic Health System will Host the Third Annual Transforming Community and Rural Healthcare
Insight
Aug 15, 2025, 14:13
Yan Leyfman: New CIBMTR Analysis
Voices
Aug 15, 2025, 13:58
Sumanta Pal Highlights Genitourinary Tumour Sessions for ESMO 2025 - European Society for Medical Oncology
Insight
Aug 15, 2025, 13:51
Claire Blondeau: Celebrating the Career of Cheryl Ashorn at MD Anderson Cancer Center
Voices
Aug 15, 2025, 13:48
Salma Jabbour: Special Summer Gathering at Rutgers Cancer Institute
Insight
Aug 15, 2025, 13:33
Gustavo Viani Highlights an Article about Dual Checkpoint Blockade Falling Short in Newly Diagnosed uMGMT GBM
Insight
Aug 15, 2025, 13:32
Howard McLeod Shared Results of NCI MATCH Study
Insight
Aug 15, 2025, 13:25
Akhil Santhosh: Nutritional Status and Outcomes in Oesophagogastric Cancer Treated with FLOT
Drugs
Aug 15, 2025, 13:15
Patrick Soon-Shiong: 30 Years and $3B Toward a Universal Cancer Fighter
Insight
Aug 15, 2025, 12:51
Castalia Fernández: Promising for Neuroprotection
Voices
Aug 15, 2025, 12:10
Jennifer S Buell: The Extraordinary Science and Unwavering Commitment of MiNK Therapeutics
Insight
Aug 15, 2025, 12:04
Talha Badar: Multi-Institutional Study on Outcomes in TP53-Mutated ALL